Skip to main content
Clinical Trials/NCT04590300
NCT04590300
Completed
Not Applicable

Impact Des Performances Cognitives et métacognitives Sur l'Apprentissage de Connaissances Lors de la réalisation de Programmes d'éducation thérapeutique

Centre Hospitalier Charles Perrens, Bordeaux1 site in 1 country108 target enrollmentOctober 6, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Schizophrenia
Sponsor
Centre Hospitalier Charles Perrens, Bordeaux
Enrollment
108
Locations
1
Primary Endpoint
Evaluation of metacognitive impairments on knowledge acquired through a therapeutic education program with Subjective Scale To Investigate Cognition in Schizophrenia (SSTICS)
Status
Completed
Last Updated
last year

Overview

Brief Summary

People with schizophrenia and bipolar disorder display alterations in cognition and metacognition. These alterations may have an impact on learning during therapeutic education programs.

Detailed Description

Patient Therapeutic Education (FTE) is defined as a practice to help patients to acquire or maintain the skills needed to best manage their lives with a chronic disease. FTE includes organized awareness, information, learning and psychological and social assistance about the disease, prescribed treatments, various treatments offered, as well as information on organization of the global health system, and health behaviours. Performed by health professionals trained in this practice, FTE is intended to help patients and their close relatives and to understand their pathology, their treatments, collaborate with health care teams, and maintain or improve their quality of life. It aims to produce a complementary therapeutic effect of other health care interventions

Registry
clinicaltrials.gov
Start Date
October 6, 2020
End Date
December 31, 2022
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Centre Hospitalier Charles Perrens, Bordeaux
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Consent to participate in the study,
  • Suffering from a chronic condition for which an therapeutic patient education (TEP) program is proposed.
  • Mastering the French language.
  • Be a beneficiary of health insurance

Exclusion Criteria

  • Poor understanding of instructions that make it impossible to consent or assess
  • Neurodegenerative disease

Outcomes

Primary Outcomes

Evaluation of metacognitive impairments on knowledge acquired through a therapeutic education program with Subjective Scale To Investigate Cognition in Schizophrenia (SSTICS)

Time Frame: 1 year

assess the impact of possible metacognitive impairments on knowledge acquired through a therapeutic education program Minimum value 21

Evaluation of cognitive impairments on knowledge acquired through a therapeutic education program with Montreal Cognitive Assessment (MoCA)

Time Frame: 1 year

assess the impact of possible cognitive impairments on knowledge acquired through a therapeutic education program Minimum value = 0 \& Maximum value = 30 Score \< 26 is considered as abnormal

Secondary Outcomes

  • assess the impact of self esteem acquired through a therapeutic education program with Rosenberg scale(1 year)
  • assess the impact of depressive symptomatology acquired through a therapeutic education program with Center for Epidemiologic Studies-Depression (CES-D) scale(1 year)
  • assess the impact of level of anxiety, acquired through a therapeutic education program with State-Trait-Anxiety Inventory (Forme Y) (STAI-Y) questionnaire(1 year)
  • assess the impact of literacy on knowledge acquired through a therapeutic education program with Rapid Estimate for Adult Literacy in Medicine (REALM-R) questionnaire(1 year)

Study Sites (1)

Loading locations...

Similar Trials